LL-37 Dosage and Protocols
LL-37 dosage protocols reported in published research, plus reconstitution and storage.
No Established Human Protocol
There is no established human clinical dosing protocol for LL-37. Vendors sell it for topical and subcutaneous research use with wide, non-standardized ad hoc dosing conventions, but no formal human pharmacokinetic or dose-finding study has ever been published, treat any specific dose figure circulating in research communities as informal convention, not validated guidance.
Reported protocol doses
Reconstitution
A 5mg vial with 2mL of bacteriostatic water is the pairing reported most often. A common research-vendor convention is a 5mg vial reconstituted with 2mL bacteriostatic water = 2500mcg/mL, this reflects vendor convention, not a validated clinical protocol.
Work out your own concentration with the reconstitution calculator.
Doses shown are those reported in published research, not a recommendation.